About AccelLAB
AccelLAB is a Healthcare company based in Boisbriand (Canada) founded in 2004, and was acquired by CiToxLAB in November 2016. Preclinical research services for medical devices are offered. AccelLAB offers products and services including Preclinical Research Services. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified.
Company details
Accel Lab is a preclinical medical device CRO offering product safety and efficacy studies. Its services include study design, sophisticated imaging technology, blood assays, histomorphometry, histopathology, and report production for regulatory submissions. Its highly specialised service portfolio also includes Endovascular studies, percutaneous procedures, Surgical interventions, Pharmacokinetics, Orthopedic and biomaterial, Histopathology and clinical pathology, Angiographic, OCT, IVUS, CT, MRI and micro-CT imaging, Cell and molecular biology. Their labs are fully AAALAC and CCAC certified. The company has been acquired by CiToxLAB in November 2016.
- Headquarters Boisbriand, Canada
- Stage Acquired
- SectorsHealthcare
- Website accellab.com
- Social LinkedIn
- Acquired by CiToxLAB (Nov 2016)
Products & Services of AccelLAB
AccelLAB offers a comprehensive portfolio of products and services, including Preclinical Research Services.
Provides safety and efficacy evaluations for medical devices.
Investors in AccelLAB
AccelLAB has secured backing from 1 investor. Prominent investors backing the company include CiToxLAB.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
In vivo and in vitro toxicology services are provided globally. | 1969 | citoxlab.com | Evreux, France |
Investor details for AccelLAB
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of AccelLAB
2 dated milestones of AccelLAB across 12 years, from founding to its latest funding, stage changes and deals.
- Founded AccelLAB is founded.
- Exit Acquired by CiToxLAB.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Accellab
Complete news archive for AccelLAB
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AccelLAB
AccelLAB was founded in 2004.
AccelLAB is headquartered in Boisbriand, Canada. It is registered at Boisbriand, Quebec, Canada.
Accel Lab is a preclinical medical device CRO offering product safety and efficacy studies. Its services include study design, sophisticated imaging technology, blood assays, histomorphometry, histopathology, and report production for regulatory submissions. Its highly specialised service portfolio also includes Endovascular studies, percutaneous procedures, Surgical interventions, Pharmacokinetics, Orthopedic and biomaterial, Histopathology and clinical pathology, Angiographic, OCT, IVUS, CT, MRI and micro-CT imaging, Cell and molecular biology. Their labs are fully AAALAC and CCAC certified. The company has been acquired by CiToxLAB in November 2016.
AccelLAB offers Preclinical Research Services.
AccelLAB has 1 investor. Key investors include CiToxLAB.
Yes. AccelLAB was acquired by CiToxLAB in November 2016.